19. April 2024
The future of functional imaging in patients with suspected Alzheimer’s dementia
If neurological and neurodegenerative diseases could be detected before the onset of severe symptoms and treated with medication at an early stage, many people could be helped. The most common neurodegenerative dementia is Alzheimer’s disease. It develops as a result of the formation of beta-amyloid oligomers and other misfolded proteins (tau) in the brain and leads to progressive memory loss. Neuroimaging scanners and, in particular, positron emission tomography (PET) systems are important for diagnosing this disease, as they can visualize the misfolded proteins. READ MORE
Michael Rindlisbacher, who will end his 35-year term this year. Schena, who has already been a member of the board of directors since 2014, will consistently continue the company’s strategy shaped by his predecessor.
